Co-Authors
This is a "connection" page, showing publications co-authored by VALENTINA HOYOS and Paul SHAFER.
Connection Strength
2.119
-
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing. Cytotherapy. 2024 03; 26(3):266-275.
Score: 0.954
-
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects. Front Immunol. 2022; 13:835762.
Score: 0.838
-
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11).
Score: 0.205
-
Pan-cancer proteogenomics expands the landscape of therapeutic targets. Cell. 2024 Aug 08; 187(16):4389-4407.e15.
Score: 0.061
-
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 Apr 25; 143(17):1726-1737.
Score: 0.061